ImageProVision’s March 2026 Newsletter highlights the company’s continued commitment to innovation, automation, and excellence in pharmaceutical and microbiological analysis. This edition introduces two advanced additions.
The newsletter also focuses on the growing impact of Artificial Intelligence in pharmaceutical analysis, where advanced imaging and analytical technologies are helping laboratories improve accuracy, reduce manual intervention, strengthen quality control, and accelerate drug development workflows. Special emphasis is given to particle characterization, microbial analysis, and thermal microscopy applications that support modern pharmaceutical R&D and QC environments.
A major highlight of the month was CLAIRITY CONNECT Indore 2026, an industry engagement event hosted by ImageProVision that brought together pharmaceutical professionals, researchers, and quality experts for discussions on AI-driven analytical technologies and intelligent microscopy solutions. The event showcased live demonstrations and application-focused discussions around particle analysis, microbial evaluation, and pharmaceutical quality control.
The newsletter also captures ImageProVision’s participation at BioAsia 2026, where the company showcased the CLAIRITY™ Suite and its wide range of applications in pharmaceutical analysis. Alongside business and technology updates, the edition celebrates the growth of the ImageProVision team with new additions, employee engagement initiatives, and activities that continue to strengthen collaboration and workplace culture.
March Newsletter Link: https://drive.google.com/file/d/1c5VKOyFU_A_kpFJg22U8pP423pZ-l0Mh/view?usp=sharing
